Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells.

Yang, C R; Guh, J H; Teng, C M; Chen, C C; Chen, P H

Yang, C R; Guh, J H; Teng, C M; Chen, C C; Chen, P H.

Affiliation

Yang CR; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan. cryang@ntu.edu.tw

Br J Pharmacol ; 157(7): 1175-85, 2009 Aug.

Article in En | MEDLINE | ID: mdl-19466993

Subject(s)

Adenocarcinoma/pathology; Anthraquinones/pharmacology; Antineoplastic Agents, Phytogenic/pharmacology; Fas Ligand Protein/pharmacology; Pancreatic Neoplasms/pathology; Phenanthrenes/pharmacology; Adenocarcinoma/metabolism; Apoptosis; Apoptosis Inducing Factor/metabolism; Cell Line, Tumor; Cell Survival/drug effects; Drug Synergism; Humans; Pancreatic Neoplasms/metabolism; Receptors, Tumor Necrosis Factor, Member 6b/biosynthesis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Phenanthrenes / Adenocarcinoma / Anthraquinones / Fas Ligand Protein / Antineoplastic Agents, Phytogenic Limits: Humans Language: En Journal: Br J Pharmacol Year: 2009 Document type: Article Affiliation country: Taiwan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google